Evidence map›Paper›PMID 18701730›Full record

ArticleJournal of epidemiology and community health2008

Racial, gender and geographic disparities of antiretroviral treatment among US Medicaid enrolees in 1998.

W D King, P Minor, C Ramirez Kitchen, L E Oré, S Shoptaw, G D Victorianne, G Rust

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in Journal of epidemiology and community health, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Paths to success: optimal and equitable health outcomes for all.Journal of health care for the poor and underserved · 2012
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

W D KingCenter for Health Promotion and Disease Prevention, Department of Family Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA 90025, USA. wking37@yahoo.com
P Minor
C Ramirez Kitchen
L E Oré
S Shoptaw
G D Victorianne
G Rust
University of California, Los Angeles · USMorehouse School of Medicine · US

Funding

TRAINING COREP20MD000182 · NIMHD · CHARLES R. DREW UNIVERSITY OF MED &SCI · PI RODRIGUEZ, MICHAEL A., SHAPIRO, MARTIN F. · 2002 to 2016
$16.5M
HIV/STD Risk Behaviors in Methamphetamine User NetworksU01DA017394 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SHOPTAW, STEVEN · 2003 to 2007
$5.2M
DREW/UCLA Project Export CenterP20MD000148 · NIMHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SHAPIRO, MARTIN F · 2002 to 2006
$3.6M
NIDA NIH HHS U01 DA017394NIDA NIH HHS U01DA17394NIMHD NIH HHS P20 MD000148NIMHD NIH HHS P20MD000148NIMHD NIH HHS P20 MD000182NIMHD NIH HHS P20MD000182
6 · The paper itself

Abstract

backgroundIn 1998, highly active antiretroviral therapy (HAART) was widespread, but the diffusion of these life-saving treatments was not uniform. As half of all AIDS patients in the USA have Medicaid coverage, this study of a multistate Medicaid claims dataset was undertaken to assess disparities in the rates of HAART.

methodsData came from 1998 Medicaid claims files from five states with varying HIV prevalence. ICD-9 codes were used to identify people with a diagnosis of HIV/AIDS or AIDS-defining illness. Multivariate analyses assessed associations between age, gender, race and state of residence for antiretroviral regimens consistent with HAART, as defined by 1998 Centers for Disease Control and Prevention (CDC) guidelines.

resultsAmong 7202 Medicaid enrolees with a diagnosis of HIV/AIDS or AIDS, 62% received HAART and 25% received no antiretroviral therapy. Multivariate analyses showed that age, race, gender and state were all significant predictors of receiving HAART: white, non-Hispanic patients were most likely to receive HAART (68.3%), with lower rates in Hispanic and black, non-Hispanic segments of the population (59.3% and 57.5%, respectively, p<0.001). Women were less likely to receive HAART than men (51.8% vs 69.3%, p<0.001).

conclusionDespite similar insurance coverage and drug benefits, life-saving treatments for HIV/AIDS diffused at widely varying rates in different segments of the Medicaid population. Research is needed to determine the extent to which racial, gender, interstate and region disparities currently correspond to barriers to such care.

Indexed as

AdultAgedAge FactorsAnti-HIV AgentsAntiretroviral Therapy, Highly ActiveDelivery of Health CareFemaleHIV InfectionsHumansMaleMedicaidMiddle AgedSex FactorsUnited StatesAnti-HIV Agents

Identifiers

PMID18701730
PMCPMC5044867
OpenAlexW2118617630

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.